Welcome members and clients of OMMP PIF. Due to increased costs, our website has moved to this server, Thanks go to our Friend and colleague, Wired57, for making this possible. If you have any questions or concerns, please start a new topic in 
Thank you 
03-21-2018, 08:52 AM
<header class="entry__header">
Suffer FromPsoriasis? This Cannabis Cream Is Here To Help
New product may be able to help 7.5 million Americans with the disease.
</header>
<a class="author url fn" href="https://thefreshtoast.com/author/mjnewsnetwork/" title="Posts by MJ News Network">MJ News Network</a>
<ul class="card__meta">
<li class="card__meta__date">
<time class="entry__date" datetime="2018-03-21T11:00:59+00:00">Mar 21, 2018</time>
</li>
</ul>
An Israeli developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders,announced it has received Institutional Review Board (IRB) approval to conduct safety testing on its proprietary topical crme compound for the treatment of psoriasis and related skin conditions.
The approval follows OWC Pharmaceutical Research Corpsextension to the size and scope of its efficacy study on the same compound, which beganNovember of 2017.
<section class="release-body container no-margin-bottom ">
<div class="col-sm-10 col-sm-offset-1">
The IRB approved study encompasses the cream itself, as a delivery mechanism, as well as the proprietary psoriasis formulation, and is the first to formally make such claims with the NIH Registry. The double-blind study, which will be conducted on healthy volunteers at one ofIsraelsleading academic hospitals, is designed to demonstrate the safety of the formulation in treating psoriasis on human skin tissue. Administrators began soliciting for study participants as soon as approval was received....
</div>
</section>
https://thefreshtoast.com/cannabis/suffe...e-to-help/
Suffer FromPsoriasis? This Cannabis Cream Is Here To Help
New product may be able to help 7.5 million Americans with the disease.
</header>
<a class="author url fn" href="https://thefreshtoast.com/author/mjnewsnetwork/" title="Posts by MJ News Network">MJ News Network</a>
<ul class="card__meta">
<li class="card__meta__date">
<time class="entry__date" datetime="2018-03-21T11:00:59+00:00">Mar 21, 2018</time>
</li>
</ul>
An Israeli developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders,announced it has received Institutional Review Board (IRB) approval to conduct safety testing on its proprietary topical crme compound for the treatment of psoriasis and related skin conditions.
The approval follows OWC Pharmaceutical Research Corpsextension to the size and scope of its efficacy study on the same compound, which beganNovember of 2017.
<section class="release-body container no-margin-bottom ">
<div class="col-sm-10 col-sm-offset-1">
The IRB approved study encompasses the cream itself, as a delivery mechanism, as well as the proprietary psoriasis formulation, and is the first to formally make such claims with the NIH Registry. The double-blind study, which will be conducted on healthy volunteers at one ofIsraelsleading academic hospitals, is designed to demonstrate the safety of the formulation in treating psoriasis on human skin tissue. Administrators began soliciting for study participants as soon as approval was received....
</div>
</section>
https://thefreshtoast.com/cannabis/suffe...e-to-help/